Malaysian Re & China Re Life sign reinsurance treaty for Cancer Precision Medicine coverage
Malaysia Reinsurance Corporation (Malaysia Re) and China Re Life Insurance Company Limited (China Re Life) have signed a landmark reinsurance treaty to support a dedicated framework for cancer precision medicine (CPM) treatment coverage in Malaysia. This marks Malaysia’s first reinsurance framework for advanced cancer treatments, including CAR-T cell therapy, targeted therapies and access to overseas…